Iqra University

Search
Close this search box.

Dr. Kanwal Iftikhar

Assistant Professor
Iqra University

Education

2015 – 2023

M.Phil./Ph.D. [Pharmacology] • cGPA 3.933 • ICCBS • University of Karachi.

2010 – 2014

Pharm-D • cGPA 3.43 •  Faculty of Pharmacy • University of Karachi.

2007 – 2009

High School Certificate (HSC) • Govt. Degree Girl’s College Sheikh Zaid Center • Karachi.

2005 – 2007

Secondary School Certificate (SSC) • Citizen Grammar School • Karachi.

Research Interests

  • Neuroscience
  • Oncology
  • Inflammation
  • Pharmacology

Biography

I am a dynamic and accomplished professional with a Ph.D. in Pharmacology from the renowned International Centre for Chemical and Biological Sciences (ICCBS) at the University of Karachi, Pakistan. With a robust foundation in academia and research, I have consistently demonstrated a self-driven, goal-oriented approach throughout my career. My academic journey includes obtaining a Pharm-D degree from the Faculty of Pharmacy at the University of Karachi. Subsequently, my pursuit of knowledge led me to achieve a Ph.D. in Pharmacology from ICCBS. Having served as a Research Fellow at ICCBS from July 2015 to May 2022, I actively engaged in diverse research projects, specializing in primary cortical and hippocampal cell cultures. My responsibilities extended to planning and designing research protocols, maintaining labs adhering to ISO standards, and collaborating with fellow researchers on various projects.

Transitioning into academia, I joined Iqra University, North Campus, Karachi, Pakistan, initially as a Lecturer from March 2023 to September 2023 and subsequently earning the position of Assistant Professor from October 2023 onwards. In this role, I am responsible for delivering lectures, conducting practical sessions, and contributing to curriculum development at both undergraduate and graduate levels. Additionally, I actively participate in establishing a molecular research laboratory within the university. Prior to my teaching role, I served as a Quality Control Executive at Dow Institute of Life Sciences, Dow University of Health Sciences, OJHA Campus, Karachi, from June 2022 to February 2023. In this capacity, I conducted stability testing of biologicals, developed stability protocols and SOPs, and validated analytical methods for biologicals.

In summary, my multifaceted career reflects a harmonious blend of academic prowess, research excellence, and a passion for contributing to the field of Pharmacology. I am poised to continue making significant contributions to both academia and research in the future.

Publications

  • Majeed, S., Aziz, A., Iftikhar, K., & Simjee, S. U. (2024). Neurogenin-2 induced neuronal differentiation in co-cultured bone marrow stromal and neonatal cortical cells. JPMA. The Journal of the Pakistan Medical Association, 74(1 (Supple-2)), S68–S73.  https://doi.org/10.47391/JPMA-DUHS-S14

 

  • Bano, P., Iftikhar, K., Rafi, K., Siddiqui, S. B., Simjee, S. U., & Begum, S. (2023). Pro-neurogenic potential of Daphne mucronata Royle.  Journal of the Chemical Society of Pakistan, 45(2).   https://doi.org/10.52568/001249/JCSP/45.03.2023

 

  • Isoxylitones Mediated Neurogenesis; Atta-ur-Rahman, M. Iqbal Choudhary, Farzana Shaheen, Shabana Usman Simjee, Saba Majeed, Anila Bashir, and Kanwal Iftikhar; US-Patent No. 11,065,211 B2, Application No. 15/934,539, Patent Date: 20/07/2021.  https://patents.google.com/patent/US11065211B2/en

 

  • Iftikhar, K., Siddiq, A., Baig, S. G., & Zehra, S. (2019). Substance P: A neuropeptide involved in the psychopathology of anxiety disorders. Neuropeptides, 101993.  https://doi.org/10.1016/j.npep.2019.101993

 

  • Aziz, A., Hanif, F., Majeed, S., Iftikhar, K., & Simjee, S. U. (2019). N-(2-hydroxyphenyl) acetamide (NA-2) elicits potent antitumor effect against human breast cancer cell line (MCF-7). Toxicology in Vitro, 60, 296-304.  https://doi.org/10.1016/j.tiv.2019.06.011

 

  • Hasan, F., Ikram, R., Simjee, S. U., Iftikhar, K., Asadullah, K., & Usman, M. (2019). Themeffects of aspirin gel and mouthwash on levels of salivary biomarkers PGE 2, TNF-α and nitric oxide in patients with periodontal diseases. Pakistan Journal of Pharmaceutical Sciences, 32(5).  http://142.54.178.187:9060/xmlui/handle/123456789/13762

 

  • Hasan, F., Ikram, R., Simjee, S. U., Iftikhar, K., & Asadullah, K. (2019). Effectiveness of Simvastatin 1% oral gel and mouthwash used as an adjunct treatment of scaling and root planning in the treatment of periodontal diseases. Pakistan Journal of Pharmaceutical Sciences, 32(6), 2673-2677.  http://142.54.178.187:9060/xmlui/handle/123456789/14521

 

  • Hasan, F., Ikram, R., Simjee, S. U., Iftikhar, K., & Asadullah, K. (2019). Effects of 1% amitriptyline gel and mouthwash in patients with periodontal diseases via local drug delivery system: A randomized control clinical trial. Pakistan Journal of Pharmaceutical Sciences, 32(4 (Supplementary)), 1855-1860.  http://142.54.178.187:9060/xmlui/handle/123456789/13331

IU ORIC is thrilled to announce that 4 innovative packaging designs from IU have been granted design patents by the Intellectual Property Organization of Pakistan (IPO). A special endorsement to Dr. Baber Khan from the Media Sciences Department for his exceptional contributions.

X
Open chat
Need help?
Hey!!
How can we help you?
Skip to content